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Abstract
Background: Classical bovine spongiform encephalopathy (BSE) is an acquired prion disease that is invariably fatal
in cattle and has been implicated as a significant human health risk. Polymorphisms that alter the prion protein of
sheep or humans have been associated with variations in transmissible spongiform encephalopathy susceptibility
or resistance. In contrast, there is no strong evidence that non-synonymous mutations in the bovine prion gene
(PRNP) are associated with classical BSE disease susceptibility. However, two bovine PRNP insertion/deletion
polymorphisms, one within the promoter region and the other in intron 1, have been associated with susceptibility
to classical BSE. These associations do not explain the full extent of BSE susceptibility, and loci outside of PRNP
appear to be associated with disease incidence in some cattle populations. To test for associations with BSE
susceptibility, we conducted a genome wide scan using a panel of 3,072 single nucleotide polymorphism (SNP)
markers on 814 animals representing cases and control Holstein cattle from the United Kingdom BSE epidemic.
Results: Two sets of BSE affected Holstein cattle were analyzed in this study, one set with known family
relationships and the second set of paired cases with controls. The family set comprises half-sibling progeny from
six sires. The progeny from four of these sires had previously been scanned with microsatellite markers. The results
obtained from the current analysis of the family set yielded both some supporting and new results compared with
those obtained in the earlier study. The results revealed 27 SNPs representing 18 chromosomes associated with
incidence of BSE disease. These results confirm a region previously reported on chromosome 20, and identify
additional regions on chromosomes 2, 14, 16, 21 and 28. This study did not identify a significant association near
the PRNP in the family sample set. The only association found in the PRNP region was in the case-control sample
set and this was not significant after multiple test correction. The genome scan of the case-control animals did not
identify any associations that passed a stringent genome-wide significance threshold.
Conclusions: Several regions of the genome are statistically associated with the incidence of classical BSE in
European Holstein cattle. Further investigation of loci on chromosomes 2, 14, 16, 20, 21 and 28 will be required to
uncover any biological significance underlying these marker associations.
Background
Transmissible spongiform encephalopathies (TSEs) are
fatal neurodegenerative diseases that have been identified
in a number of mammalian species (humans, cattle,
sheep, mice, etc.) [1]. One of the common characteristics
of these diseases is the accumulation of abnormally
folded prion protein within the central nervous system.
The prion protein is a glycosyl-phosphatidylinositol
(GPI) anchored protein that has a native form (PrP
c)f o r
which the secondary structure consists mainly of alpha-
helices. The disease-associated or misfolded form, PrP
Res,
has a substantial increase in the beta-pleated sheets con-
tent and reduction of the alpha-helices in comparison to
the native form [2]. This altered confirmation is asso-
ciated with an increased resistance to digestion with pro-
teinase K [3]. Furthermore, the presence of PrP
Res
behaves like a seed that promotes the conversion of
further native PrP
c to PrP
Res via a mechanism that is to
date not completely understood [4].
Specific PRNP alleles of non-synonymous polymorph-
isms in humans and sheep are associated with acquired
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although the deletion alleles of a 23 base pair insertion/
deletion (InDel) polymorphism in the bovine PRNP
promoter region and of a 12 base pair InDel within
intron 1 have been associated with incidence of classical
bovine spongiform encephalopathy (BSE) [9-11]. Both of
these polymorphisms are contained in a block of high
linkage disequilibrium (LD) within PRNP that appears
conserved in many cattle populations, and is entirely
outside of the coding region [12]. Thus, the full extent
of PRNP association with classical BSE is currently not
known. Previous genetic studies of BSE cattle have iden-
tified putative loci other than PRNP (located on chro-
mosome 13 at 47.2 Mb) that are associated with
incidence of disease [13,14]. These studies carried out
low density whole-genome scans with microsatellite
markers approximately every 20 cM in female European
Holstein cattle which contracted BSE and unaffected
half-sib controls.
The objective of this study was to test loci throughout
the bovine genome for an association with classical BSE
using markers at 2 cM resolution. This resolution is
approximately a ten-fold improvement over previous
genome scans of BSE samples. Two animal sample sets
were used, allowing for two analysis approaches: a case-
control association study and family based sib-transmis-
sion disequilibrium test (sib-TDT) study [13,14]. In both
sample sets the cattle used were female European Hol-
stein cattle which contracted BSE in the late 1980’sa n d
early 1990’s (family analysis) and in the mid-1990’s
(case-control analysis) and were identified on commer-
c i a lf a r m sw h e r et h em o s tl i k e l ys o u r c eo fd i s e a s ew a s
through consumption of contaminated feed during the
United Kingdom’s BSE epidemic. Although the United
Kingdom imposed a ruminant feed ban of meat and
bone meal in June 1988, it wasn’t until August 1996
that a total ban on bovine meat and bone meal was
implemented [15].
Results
The panel of SNP markers used in this study consisted
of 3,072 SNPs dispersed across the genome at an
approximate average interval of 2 cM [16]. Of these,
an average 2,853 passed quality control measures and
had an average genotyping success rate of 0.99. The
samples used in this study came from two sets of ani-
mals with different relatedness that allowed for the use
of several statistical analyses to test the association
between SNP genotypes with classical BSE incidence.
By using both offspring from six sires (sib-TDT) and
(case-control) Holstein animals, this study examined
within-breed and within-family SNP association with
disease incidence.
Family based association testing for BSE incidence
The related sample set (N = 481) was comprised of six
paternal half-sib sire families of which 4 were scanned
previously with microsatellites [13,14]. Samples were not
available from either the sires or the dams; therefore,
the sib-TDT analysis method [17] was used. Addition-
ally, PLINK software [18] was used to establish an
empirical p value and determine significance. The
results for this sib-TDT analysis (412 animals across
2,827 SNPs after quality control) identified 46 SNPs that
passed the Bonferroni correction with a p < 0.05 and 27
SNPs that passed the Bonferroni correction with a p <
0.01 (Table 1). In addition, a 10,000,000 permutation
test was performed on this data using the PLINK “max
T” to establish genome wide empirical p values. The
genome wide 10,000,000 permutation identified 31 SNPs
with an empirical permutation of p < 0.01. This group
of SNPs included the 27 SNPs which passed the Bonfer-
roni at p < 0.01 plus four additional SNPs. Many of
these SNPs are located in very close proximity [16] to
one another and are potentially in LD in the population.
Case-control association testing for BSE incidence
The case-control samples were comprised of 149 BSE
case and 184 control animals. The control samples
include a least one animal collected from the same farm
as each of the BSE cases as well as the controls for, and
15 BSE negative animals. The genotyping data on these
animals was analyzed for an association with disease sta-
tus using the case-control allelic test within the PLINK
software [18]. This analysis (320 animal across 2,872
SNPs after quality control) revealed 20 SNPs with a
p < 0.01, 14 SNPs with a p < 0.005 and 6 SNPs with a
p < 0.001. In order to determine the number of these
SNPs that may have occurred by chance, an empirical p-
value for each single SNP and across all SNPs (genome
wide) was calculated using the max (T) permutation pro-
cedure with 10,000 permutations. Following correction
for the false discovery rate no significant associations at p
≤ 0 . 0 5g e n o m e - w i d es i g n i f i c a n c ew e r ei d e n t i f i e di nt h i s
data set. This was consistent with the use of Bonferroni
multi-test correction on this data set, where again none
of the SNPs achieved significance of p ≤ 0.05. To assess
significance a threshold was set at p ≤ 1.7 × 10
-5 (Bonfer-
roni calculation). Twenty SNPs were identified with
p < 0.01 (Table 2), where four SNPs had a p ≤ 5×1 0
-4
and one SNP had a p ≤ 1×1 0
-4. Thus a single SNP had a
suggestive association with BSE incidence on chromo-
some 14 (p = 7.25 × 10
-5). SNPs which did not quite
reach this threshold but had a p ≤ 5×1 0
-4 were found
on chromosomes 4, 10, 14, and 15. The number of loci
on each chromosome, the identity of these specific SNPs
and their corresponding p-values are reported in Table 2.
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where the standard allelic, trend, dominance, recessive
and genotypic association tests were performed, and the
test with the lowest p value was reported. All of the
SNPs identified above were also identified in the best fit
model as either allelic or trend, however additional SNPs
with recessive, dominant and genotype associations were
also identified. In the best fit model there were a total of
fourteen SNPs with a recessive mode of action, seven
dominant SNPs and eight genotypic SNPs with a p <
0.01 (see Additional file 1). Using the same thresholds as
described above, (i.e. significant with a p ≤ 10
-5 and sug-
gestive with a p ≤ 10
-4), one SNP on chromosome 14
had a suggestive association with BSE incidence.
Discussion
Classical BSE as a phenotype
Clinical presentation of BSE disease is a difficult pheno-
type to test for genetic associations. Animals that have
developed BSE are clearly susceptible, however, those
which are clinically healthy are difficult to assess. In the
present study, clinically healthy animals were used as
controls, however, these animals may have been incu-
bating disease or may not have ingested enough infec-
tious agent to become symptomatic, or alternatively,
they may in fact have been resistant to disease. There-
fore, the analysis was performed with the realization
that phenotypic noise in the controls will have reduced
the power to detect associations. Another consideration
is that classical BSE is a complex trait which may be
more consistent with interactive and possibly subtle
effects of multiple contributing loci. Therefore, multiple
testing corrections applied to results such as these may
be overly prone to type II errors (i.e. discarding real
associations). Consequently, it is important to examine
the results for supporting evidence of associations
between disease and genetic loci, as discussed below.
PRNP gene
PRNP variation was not exhaustively tested for an asso-
ciation with classical BSE as the focus of this study was
primarily genome wide. Over 380 polymorphisms are
Table 1 The results of sib-TDT model analysis using the large family sample set.
Location unadjusted permuted
SNP ID CHR bp Gene p value p value Bonferroni
AAFC02065030 2 37,055,124 1.93E-08 3.61E-05 5.45E-05
rs29020694 4 90,418,076 1.87E-06 4.05E-03 5.29E-03
AAFC02132123_1 4 117,126,683 LOC100138299 9.38E-07 1.98E-03 2.65E-03
AAFC02132123_2 4 117,126,810 LOC100138299 3.38E-06 7.33E-03 9.55E-03
AAFC02012009 5 30,554,866 LOC507184 3.53E-06 7.69E-03 9.98E-03
rs29003193 5 66,501,993 3.12E-08 5.79E-05 8.82E-05
rs29012226 5 67,701,052 ANKS1B 6.63E-07 1.38E-03 1.87E-03
SCAFFOLD106936 6 98,767,642 6.35E-07 1.32E-03 1.80E-03
rs29016161 7 24,604,791 2.45E-06 5.31E-03 6.93E-03
rs29017305 9 62,946,258 BACH2 2.30E-06 4.97E-03 6.49E-03
rs29013631 10 38,725,566 2.25E-06 4.87E-03 6.36E-03
rs29022366 12 80,076,729 LOC786668 2.74E-06 5.95E-03 7.75E-03
rs29010388 14 4,145,186 4.20E-07 8.56E-04 1.19E-03
AAFC02138417 15 70,632,844 3.31E-06 7.19E-03 9.36E-03
rs29010371 16 63,558,950 FAM129A 1.06E-06 2.26E-03 3.00E-03
rs29009572 17
# 37,575,810 1.29E-06 2.76E-03 3.65E-03
rs29021871 17 44,213,230 1.06E-06 2.25E-03 2.99E-03
CART 20
# 4,922,252 CART 3.57E-08 6.75E-05 1.01E-04
rs29018531 20 38,814,738 1.32E-06 2.82E-03 3.72E-03
AAFC02028192 21 5,702,403 MEF2A 1.24E-07 2.49E-04 3.49E-04
rs29022862 21 12,595,937 1.85E-07 3.73E-04 5.22E-04
rs29009825 21 24,827,395 1.90E-06 4.11E-03 5.38E-03
rs29012664 22 42,415,179 FHIT 5.30E-07 1.10E-03 1.50E-03
NW_930303_1 24
# 29,286,364 1.02E-07 2.05E-04 2.90E-04
NW_930303_2 24
# 29,286,314 3.06E-07 6.17E-04 8.64E-04
SCAFFOLD176855 28 26,871,628 SLC29A3 1.03E-06 2.18E-03 2.90E-03
SCAFFOLD68962 X 7,641,750 3.15E-06 6.86 E-03 8.91E-03
Locations were determined by blast to bovine sequence version 4.0. All other locations denoted by
# were either determined from bovine sequence version 2.0,
4.1 or the Maryland sequence assembly. Permuted p values reported here are from a 10,000,000 genome-wide SNP permutation.
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regions of PRNP [12]. Of these, 13 PRNP haplotype tag-
ging SNPs (htSNPs) were used in the scans of which 8
were informative for both data sets. The htSNPs used in
this study capture a large portion of PRNP haplotype
variation observed in a diverse assemblage of U.S cattle,
spanning the promoter region into the last exon, how-
ever, they do not capture all of it. Additionally, the two
InDels previously identified [9-11] as having allele asso-
ciations with classical BSE were not genotyped in this
study and thus no information is available for this sam-
ple set and the InDels PRNP haplotypes. One SNP
(PRNP08) had a p value of 4.38 × 10
-3 for an association
with classical BSE but did not pass multiple test correc-
tions. Consequently, no significant associations of PRNP
variation (the 8 informative htSNPs) with classical BSE
were identified in this single marker analysis. Given that
the single marker analysis of the informative htSNPs did
not capture all of the htSNPs in the PRNP region or the
two InDels it should not be considered an exhaustive
analysis of the PRNP gene region.
Family-based analysis
Family-based analyses, although in general being less
powerful than case-control studies [19], offer robustness
to non-random mating. The transmission/disequilibrium
test developed in 1993 by Spielman [17] is intended to
test for linkage between complex diseases and genetic
markers. The sib-TDT approach used here does not
reconstruct parental genotypes in their absence, but
uses marker data from unaffected half siblings instead
[17]. The DFAM analysis model fits the structure of the
related half-sibling sample set and has been utilized in
other species as well [20]. The study presented here
used a much larger number of markers than the pre-
vious studies and used an analysis approach that is
robust to population stratification [21]. The advantage
this analysis has over the case-control approach is that
with 302 affected animals it has twice the number of
affected individuals, and thus, a higher study power and
likelihood of detecting markers associated with disease
loci.
Many of the samples included in the family sample set
used in this study were also used by Hernández-Sánchez
et al.[ 1 3 ]a n dZ h a n get al. [14], while the case-control
sample set was analyzed here for the first time. Hernán-
dez-Sánchez et al. [13] also used a TDT approach, how-
ever, their analysis method requires heterozygous
parents to allow the parent of origin of alleles to be
unequivocally determined and as a result many animals
had to be disregarded in their analysis. In addition, pro-
geny with the same genotype as the predicted genotype
of the sires or progeny that were themselves homozy-
gous were excluded. As a result, although the TDT
method used by Hernández- Sánchez et al.[ 1 3 ]h a st h e
potential to be powerful, the use of this approach with
microsatellite marker based data was limited by the
number of genotypes which could be used and ranged
from 92 (in the case of marker BMS1658) to 210 (in the
case of INRA36). The analysis method used to localize
QTLs by Zhang et al. [14] was a regression approach
which does not require the parents to be heterozygous
and hence all individuals could be included in the analy-
sis. However, the QTL approach is not robust to popu-
lation stratification. Moreover, the total number of
samples (360) used in the Zhang et al. [14] study was
smaller than that of Hernández-Sánchez et al. [13] (530)
as well as this study (412). The two previous analyses of
overlapping family samples yielded different results: the
TDT analysis of Hernández-Sánchez et al.[ 1 3 ]f o u n d
evidence for associations with BSE incidence on chro-
mosomes 5, 10 and 20, whereas the QTL analysis by
Zhang et al. [14] identified BSE associated QTL chro-
mosomes 1, 6, 13, 17, 19 and X/Yps. SNPs in the regions
matching regions found in previous studies are detailed
in Table 3. With regards to the family data this study
offers a similar power to that of the TDT analysis by
Hernández-Sánchez et al. [13], however uses half-sib
controls as opposed to inferring the sires genotype. In
addition, due to necessary genotypic restrictions (only
Table 2 PLINK case-control association results of the
case-control sample set.
Location unadjusted
SNP ID CHR bp Gene p value
rs29013431 2 15,312,400 5.99E-03
rs29012194 2 26,095,592 6.28E-03
rs29016537 2 29,654,789 1.30E-03
rs29020907 4 59,252,723 IMP2 4.97E-04
rs29024570 10 4,359,586 4.30E-04
AAFC02107025 10 21,153,203 DHRS1 4.73E-03
rs29024728 13 28,618,368 3.34E-03
PRNP08 13 47,214,453 PRNP 4.38E-03
rs29021171 14 10,106,755 3.84E-03
SCAFFOLD51887 14 43,984,153 7.25E-05*
rs29014819 15 35,713,980 7.17E-04
rs29014820 15 35,714,095 6.05E-04
rs29014821 15 35,714,113 4.66E-04
AAFC02014662 16 65,943,749 7.95E-03
AAFC02012500_1 21 11,820,092 MCTP2 1.82E-03
AAFC02012500_2 21 11,820,201 MCTP2 3.93E-03
rs29026011 21 13,254,954 LOC618464 3.00E-03
rs29019629 21 33,209,686 CSPG4 2.01E-03
rs29011202 24 18,493,192 9.08E-03
AJ496776 28 31,495,721 5.74E-03
All locations determined by blast to bovine sequence version 4.0. Threshold of
significance is p ≤ 1.7 × 10
-5 and suggestive significance p ≤ 10
-4 is denoted
as *.
Murdoch et al. BMC Genetics 2010, 11:20
http://www.biomedcentral.com/1471-2156/11/20
Page 4 of 10heterozygous genotypes can be used) of the TDT
method, the approach used here allowed for a greater
number of animals to be included in the analysis.
Although the total number of animals used in this ana-
lysis includes two smaller families (6 families versus 4
families in the previous studies [13,14]) this analysis
method does not infer sire genotypes and therefore the
inclusion of the two smaller families do not reduce the
overall power of this analysis.
The sib-TDT analysis in this study identified two sig-
nificant SNPs on BTA 20 associated with BSE incidence,
rs29018531 at 38.8 Mb and a SNP within the cocaine
and amphetamine responsive transcript peptide gene,
(CART). CART is not currently on the Btau4.0 bovine
sequence assembly but was previously mapped to chro-
mosome 20 at 38.5cR [15]. In addition, the location of
CART was reported on Btau2.0 as 4.92 Mb as well as
the Maryland map as 9.78 Mb. Therefore it is unclear
from this study if the observed associations identified
here are attributable to one locus or two separate loci.
The study of Hernández-Sánchez et al. [13] observed an
association with marker INRA36 (at 37.9 Mb) on BTA
20 with BSE incidence. This study also identified signifi-
cant markers on chromosomes 5, 6, 10, 17 and X asso-
ciated with BSE. The study by Hernández-Sánchez et al.
[13] also reports associations on BTA 5 and 10 but did
not report confidence intervals. The marker identified
on BTA 6 in this study (Table 3) is in the same chromo-
somal region as the marker described by Zhang et al.
[14] and is within the confidence interval. The precise
location of these significant markers can be found in
Table 3. Moreover, the significant marker on BTA 6,
Scaffold106936 at 98.7 Mb corresponds with the QTL
region, 51-72 cM on mouse chromosome 5, previously
associated with susceptibility to TSE in mice [22]. Addi-
tionally, the homologous region to that identified on
BTA 6 was also identified as a QTL modulating scrapie
incubation period in sheep [23]. Interestingly, the QTL
region on mouse chromosome 5 described by Moreno
et al. [22] also corresponds to the location of a signifi-
cant SNP identified on BTA 17, 44.2 Mb. Thus these
chromosomal regions identified in the present study are
also supported by studies in cattle and other species.
Comparative locations were determined by using the
National Center for Biotechnology information map
viewer of the mouse QTL regions (build 37.1), then the
human and Btrna were selected and bovine locations
were determined.
In QTL studies in mice Monero et al., 2008 [22] and
Llyod et al., 2002 [24] used a panel of 72 microsatellites
to examine 282 F2 and 124 F2 mice respectively. How-
ever these mice were inoculated intracerebrally as com-
pared to our study where infectious material was orally
ingested through contaminated feed. Comparatively
these studies have fewer animals and although they use
microsatellite markers the information content is limited
due to the fact that both studies only use 2 inline bred
strains. In addition, it should be noted that single mar-
ker association analysis, as reported in this manuscript
differs from QTL analysis. These differences make direct
Table 3 Comparison of SNPs observed in this study with locations indentified in other studies.
Analysis Location Previously Peak
CHR SNP ID Method p-value Mb Observed Location Mb
1 rs29009859 sib-TDT 2.0 × 10
-5 89.7 [14] 106.5
5 AAFC02012009 sib-TDT **9.9 × 10
-3 30.6 No
5 E25B16-36408-3 sib-TDT **8.8 × 10
-5 66.5 No
5 rs29012226 sib-TDT **1.9 × 10
-3 67.7 No
5 rs29024670 sib-TDT 3.0 × 10
-5 112.8 [13] 107.0
6 SCAFFOLD106936_12205 sib-TDT **1.8 × 10
-3 98.8 No
10 rs29024570 Case-control *4.3 × 10
-4 4.4 No
10 rs29013631 sib-TDT **6.5 × 10
-3 38.7 No
10 rs29015623 sib-TDT 9.0 × 10
-5 48.0 [13] 40.0
17 rs29021871 sib-TDT **3.0 × 10
-3 44.2 No
19 rs29027102 sib-TDT 2.0 × 10
-5 62.5 [14] 53.5
20 rs29018531 sib-TDT **3.7 × 10
-3 38.8 [13] 46.0
20 CART-SNP sib-TDT **1.0 × 10
-4 4.9
# No
X SCAFFOLD68962_9331 sib-TDT **1.0 × 10
-5 7.6 No
X SCAFFOLD285727_12117 sib-TDT 1.0 × 10
-5 85.5 [14] 112.5
Sib-TDT p values are reported as unadjusted unless denoted by ** which indicates Bonferroni corrected values that pass 10,000,000 permutations. All case
control p-values are reported are as unadjusted and suggested significance is denoted as *. Only SNPs with appreciable or significant p-values located within the
confidence intervals of ref# [14] or within 10 cM of ref# [13] are reported here. The location determined by older bovine sequence version 2.0 is denotedb y
#.A l l
other locations were determined by blast to bovine sequence version 4.0 and are reported in mega bases. The previous studies reported location in cM however
for the sake of uniformity the location is reported here, based on marker positions, in Mb.
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nor the previous studies, even in other species, can
really be considered comprehensive genome scans they
suffer from the same shortfalls. In this study there
remains the distinct possibility of a type 2 error which
fails to identify a genome location that is associated
with disease.
Case-control analysis
In selecting the analysis approach, it is important to
match the appropriate model to the data structure to
maximize the power. This study used a case-control
approach to analyze the paired control with BSE ani-
mals. This approach is powerful in its ability to detect
loci linked with disease: however, it has been criticized
by geneticists for its lack of robustness for population
stratification arising from non-random mating or
unknown relationships between individuals [19]. The
data presented here was examined for stratification and
none was observed (see Additional file 2). However, it is
likely that some family relationships exist between some
of the cases and controls but the extent and the effect
was unable to be determined. Despite the power of the
case-control approach, this study was limited by the
relatively small number of animals used (149 cases and
184 controls) and no significant results were observed.
An increase in the number of cases and controls
included in this sample set would have a dramatic effect
on the power to detect loci associated with disease [19],
as would a higher density scan conducted with an
increased number of genome-wide markers.
Shared regions identified in the sib-TDT family and
implicated in the case-control analysis
Many of the SNPs included in the panel are in close
p r o x i m i t ya n da r ei nL Di nH o l s t e i n[ 1 6 ] .T h e r e f o r e ,i t
m a yb em o r ea p p r o p r i a t et oc o n s i d e rt h er e s u l t si n
terms of chromosomal regions instead of individual
markers. Linkage disequilibrium will result in the alleles
of several closely spaced SNPs being associated with dis-
ease status because they all fall on the same haplotype.
Thus, it would be expected that several SNPs in LD
with a locus involved in disease would show significant
associations. Examples of this can be observed with the
loci on BTA 15 in Table 2 as well as BTA 4 in Table 1.
In addition, if the same regions give significant or a
nearly significant association across the different sample
sets, this would also increase confidence that the asso-
ciation is real. Chromosome 2 is a good example: the
most significant marker in this study, AAFC02065030,
with a Bonferroni corrected p = 5.5 × 10
-5 in the family
based analysis is at 37.1 Mb on this chromosome. In the
case-control samples set, three markers were identified
on Chromosome 2, one at 15.3 Mb, another at 26.1 Mb,
and the last (p = 1.0 × 10
-3) at 29.7 Mb. From the dif-
ferent analyses methods and across the two sample sets
four markers were identified in the chromosomal region
from 15.3 Mb-37.1 Mb on BTA2, with the region of 29-
37 Mb being significant. This data supports an associa-
tion between chromosome 2 and BSE disease, however
f r o mt h ed a t ai tc a n n o tb ed e t e r m i n e di ft h i se f f e c ti s
from one locus or several loci spread across the region.
Another chromosomal region which harbours signifi-
cant markers that were identified in the family-based
analyses and was observed but failed to reach significance
in the case-control analysis is on chromosome 21. Four
SNPs were observed on BTA 21 from the analysis of
case-control samples, two SNPs which are located at 11.8
Mb (p = 4.4 × 10
-3 a n dp=8 . 3×1 0
-3)i nt h eMCTP2
gene, another at 13.3 Mb (p = 2.5 × 10
-3) in LOC618464,
and an additional SNP at 33.2 Mb (p = 2.0 × 10
-3)i nt h e
gene CSPG4. The family based sib-TDT analysis identi-
fied three significant SNPs, at 5.7 Mb in the MEF2 gene
( p=3 . 5×1 0
-4), 12.6 Mb (p = 5.2 × 10
-4), and 24.83 Mb
(p = 5.4 × 10
-3). When considering both sample sets
there appears to be an interval from 11.8 Mb-13.3 Mb
with the outer range of approximately 5.7-33.2 Mb for a
locus with an effect on BSE. BTA 21 shares conservation
of synteny with sheep OAR 16 where QTLs for scrapie
susceptibility and scrapie incubation period have been
reported [25].
Regions containing loci significantly associated with
disease status identified on chromosomes 14, 16 and 28
in the sib-TDT analysis of the family-based data were
also observed to be of interest, but failed to reach signif-
icance, in the case-control study. On chromosome 14
the marker, rs29021171, at 10.1 Mb had a p = 2.3 × 10
-3
in the analysis of case-control animals and is in relative
close proximity to, rs29010388, at 4.2 Mb which was
identified as significant in the sib-TDT analysis (p = 1.2 ×
10
-3). On chromosome 16 marker AAFC02014662 at 65.9
Mb identified in the case-control (p = 7.95 × 10
-3)i si n
close proximity to rs29010371 at 63.5 Mb, which is in the
gene FAM129A, that was identified as significant (p = 3.0
×1 0
-3) in the sib-TDT analysis. Finally on chromosome
28 marker AJ496776, at 31.5 Mb identified in the case-
control sample analysis (p = 9.9 × 10
-3)i si nc l o s ep r o x i -
mity to the marker SCAFFOLD176855 (within SLC29A3
gene) at 26.9 Mb identified as significant (p = 2.9 × 10
-3)
in the sib-TDT analysis. None of these chromosomal
regions have been previously reported as being associated
with BSE.
Candidate genes identified in the case-control and/or
sib-TDT family analysis
The SNPs identified from the family samples on chro-
mosomes 4, 5, 9, 12, 16, 20, 21, 22 and 28 are all found
within genes; however, the polymorphisms on
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most notable is the polymorphism on chromosome 5,
rs29012226, in the ankyrin repeat and sterile alpha
motif domain containing 1B gene (ANKS1B). This gene
is also known as amyloid beta protein precursor (APP)
intracellular domain associated protein 1 (AIDA-1), and
is associated with APP binding [26]. It is well known
that APP generates beta amyloid and plays a key role in
Alzheimers disease [27-30]. Further cellular prion pro-
tein and AIDA-1 has been implicated as a receptor for
amyloid-b oligomers [31,26], making ANKS1B ag o o d
candidate gene for further study.
Another candidate gene, which is in close proximity to
three SNPs on BTA 2 at ~29.3 Mb, with alleles that
associated with BSE incidence is B3GALT1. Beta-1,3-
galactosyltransferase (B3GALT1), is a transferase poly-
peptide gene involved in the biosynthesis of GPI
anchors. The involvement of the GPI anchor, with lipid
raft and TSE disease has been investigated [32] and it is
thought that the GPI anchor may affect the conforma-
tion, or the association of the prion protein with specific
membrane domains [33]. An additional potential candi-
date gene is CART, cocaine and amphetamine regulate
transcript. This neuropeptide plays a role in a variety of
physiological processes, some of which include: promo-
tion of hippocampal neurons by upregulating brain-
derived neurotrophic factors [34] and synaptogenesis
[35]. In addition, the expression of CART has shown to
be down regulated in mouse prion disease [36].
The SNP located on BTA 14 (43.9 Mb), associated
with BSE incidence in the case-control analysis, is in
close proximity to the gene exostoses (multiple) 1,
EXT1. McCormick et al., [37] showed that EXT1 is an
endoplasmic reticulum (ER)-resident type II transmem-
brane glycoprotein whose expression in cells results in
the alteration of the synthesis and display of cell sur-
face heparan sulfate glycosaminoglycans (GAGs). The
N terminus of PrP contains a GAG-binding motif and
it is thought that PrP binding of GAG is important in
prion disease [37-39]. Additionally, this region contains
another candidate gene STMN2, which has been identi-
fied in a whole genome association study for genetic
risk factors for variant Creutzfeldt-Jakob in humans
[40]. Specifically, Mead and others [40] found an asso-
ciation with acquired prion diseases, including vCJD
(p = 5.6 × 10(-5)), kuru incubation time (p = 0.017),
and resistance to kuru (p = 2.5 × 10(-4)), in a region
upstream of STMN2 (the gene that encodes SCG10).
Superior cervical ganglion 10, SCG10,i san e u r o n a l
growth associated protein and may play a role in neu-
ronal differentiation in modulating membrane interac-
tion with the cytoskeleton during neurite outgrowth.
STMN2 is at 39.9 Mb on chromosome 14 in cattle,
which is in close proximity to EXT1, making both
STMN2 and EXT1 are functional and positional gene
candidates.
Conclusions
The large number of SNP markers and the two sets of
animals used in this study make it the most comprehen-
sive study to date to test genetic loci for an association
with classical BSE in European Holstein cattle. The
genome-wide scan of half sib families identified an asso-
ciation between the genetic loci on 18 chromosomes
with BSE incidence in European Holstein cattle, includ-
ing a region on BTA 20 associated with BSE incidence
that has been reported in previous studies. The identifi-
cation of markers at or near statistical significance within
the same chromosomal regions in both sets of samples
provides independent evidence for the association of
those regions and the presence of one or more genes
within the regions influencing the incidence of BSE in
cattle. However, these results need to be confirmed in
additional cattle populations or other species. The data in
this study can be made available upon request.
It is worth noting that this study identified a large
number of associations with classical BSE disease inci-
dence throughout the bovine genome versus one single
major locus with a large effect in the bovine genome.
This would make it difficult to select cattle that are
genetically resistant to classical BSE, however the results
give some insight into gene pathways important during
disease progression.
Methods
Animal information
This study used two sets of samples from cases and
controls, but with different structures. The first sample
set consisted of female European Holstein collected in
the mid 90’s and included 149 BSE case and 184 control
animals. The control animals were contemporaries of
the BSE cases and collected from the same farms. In
addition 15 BSE negative, determined by post-mortem
histology, and paired control animals were included in
the control set. The second sample set was family based
and consisted of 302 BSE affected and 179 unaffected
half-sib Holsteins from six sire families. All the BSE
affected and unaffected cattle within one family were
paternal half sibs from the designated sire but with dif-
ferent dams. No DNA samples were available from any
of the sires.
In both sample sets cattle designated as BSE positive
were first examined by qualified veterinarians. BSE sta-
tus was subsequently confirmed post-mortem by histol-
ogy (by the Veterinary Laboratories Agency, New Haw,
Surrey, UK). None of the control animals exhibited any
clinical symptoms of disease and were presumed to be
free of disease. All of the control animals were age and
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same farm as the BSE cases. As such, the control ani-
mals are assumed to have been exposed to the same
environment.
DNA isolation and genotyping
Genomic DNA from the case-control was isolated from
blood using a high salt phenol/chloroform extraction
method as described by Sherman et al.[ 4 1 ] .G e n o m i c
DNA from the family animal set was isolated from
blood samples by phenol and chloroform extraction, as
described by Hernández-Sánchez et al. [13].
The genotyping panel was comprised of two oligonu-
cleotide pool assays (OPAs) as described by McKay and
others in 2007 [16]. Briefly, 5,500 SNP were mapped on
the Roslin-Cambridge 3,000 rad bovine-hamster whole
genome radiation hybrid panel (WGRH3000) [42] and
the minor allele frequency( M A F )w a sd e t e r m i n e do na
variety of breeds, including Holstein. Of the original
SNPs, 3,072 were selected to give the greatest genome
coverage and MAF >0.05 for the genome scan. An Illu-
mina GoldenGate assay [43] was performed using the
two custom OPAs and genotypes determined using an
Illumina BeadScan (Illumina Inc., San Diego, CA) and
the Illumina BeadStudio software. Sequences containing
SNPs (see additional file 3) were blasted on the bovine
assembly (4.0) to determine the SNP locations [16] and,
the location for all except 111 SNPs were determined.
Data quality control
Quality control analyses were carried out by removing
confounding effects prior to the data analysis. For the
case-control sample set from the original 3,072 SNPs in
the assay, 122 SNPs were excluded based on assay fail-
ure, as observed by poor clustering of alleles using the
BeadStudio software. The remaining 2,950 SNPs were
submitted to the PLINK program [18] where seven
duplicated SNPs were removed and 12 SNPs were
removed because more than 10% of the samples failed
to genotype at that locus (GENO >0.1). Additionally, 13
samples were removed due to low genotyping rate
(MIND>0.1). A further 61 SNPs were removed due to a
MAF <0.01. The MAFs for each of the SNPs in this
data set is provided in additional file 3 and the graphical
representation of the MAF for each chromosome is
shown in additional file 4. The remaining individuals
that were included in the analyses had a mean genotyp-
ing rate of 0.995. Population stratification was tested for
in this data set and none was observed (data in addi-
tional file 2).
For the family sample set, transmission disequilibrium
analysis was performed using the sib-TDT application in
the PLINK program. Following the removal of SNPs
that did not cluster well, 2,904 SNPs were used in the
analysis. Of these loci, a further 22 SNPs were removed
due to missing data (GENO>0.1), seven duplicated
SNPs, and a further 48 SNPs were removed due to low
allele frequency (MAF<0.01). The MAFs for each of the
SNPs in this data set is provided in additional file 3 and
the graphical representation of the MAF for each chro-
mosome is shown as in additional file 4. Of the indivi-
duals examined, 5 samples failed and 64 were removed
because of low genotyping frequency (MIND>0.1), for
the 412 remaining individuals (see Table 4) a genotyping
success rate of 0.98 was obtained.
Statistical analysis
The PLINK software v1.04 was used to perform the
majority of the statistical analysis [18]. The data from
the case-control sample set were analyzed using the
basic case-control association (c
2) test. Whereas the
family sample set was analyzed with the DFAM program
[18], which is an adjusted family TDT analysis, as
described by Spielman [17]. To correct for multiple tests
Bonferroni single-step adjusted p-values (BONF) proce-
dures were applied. A permutation test was also used in
this study, which was max(T)” permutation with 10,000
and 10,000,000 permutations, a procedure that permutes
both a point-wise SNP significance and a genome-wide
significance.
Additional file 1: The best fit model analysis results (Genotypic,
Recessive, and Dominant) of the case-control sample set.
Additional file 2: Multi-dimensional Scaling (MDS) of the multiple
family sample set and unrelated sample set.
Additional file 3: Sequence information for the SNPs and the minor
allele frequencies for the family and case-control sample sets in
order of position.
Additional file 4: Graphical plots of the MAF versus position for
each chromosome for the multiple family sample set and unrelated
sample set.
Table 4 The sire identities and the number of half sib
offspring analyzed in this study verses the number of
animal used two previous studies.
Sire Number of BSE Number of control
This study [13] [14] This study [13] [14]
Barold Rock Seal 33 53 43 11 28 22
Brynhyfryd Cascade 68 93 72 28 56 18
Leighton Workboy 71 88 70 40 44 22
Maybar Juniper 90 124 83 51 44 30
Bowerchalk Polacca 4 0 0 6 0 0
Deri cascade 3 0 0 7 0 0
Total 269 358 268 143 172 92
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